Vicks 44 claims
This article was originally published in The Tan Sheet
Executive Summary
National Advertising Division of the Council of Better Business Bureaus announces Dec. 9 that Procter & Gamble did not respond to an inquiry initiated by NAD on Nov. 14 regarding advertising claims for Vicks 44 within the allotted 15 business days. American Home Products brought the Vicks ads to NAD's attention, alleging that commercials for Vicks 44 Maximum Strength Cough Syrup (now renamed Vicks 44 Dry Hacking Cough Syrup) erroneously implied overall superior efficacy. P&G said it would respond to the challenge within a second 15-day period, NAD said
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning